|
C22ORF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.828100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.975800E-02 |
| Normal-vs-Stage2 |
2.146200E-01 |
| Normal-vs-Stage3 |
9.651600E-01 |
| Normal-vs-Stage4 |
3.264400E-01 |
| Stage1-vs-Stage2 |
7.534600E-01 |
| Stage1-vs-Stage3 |
2.473000E-01 |
| Stage1-vs-Stage4 |
1.086790E-01 |
| Stage2-vs-Stage3 |
2.799000E-01 |
| Stage2-vs-Stage4 |
1.265200E-01 |
| Stage3-vs-Stage4 |
4.037200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.909650E-02 |
| Normal-vs-AfricanAmerican |
3.253600E-01 |
| Normal-vs-Asian |
1.499610E-01 |
| Caucasian-vs-AfricanAmerican |
4.125600E-01 |
| Caucasian-vs-Asian |
2.280000E-02 |
| AfricanAmerican-vs-Asian |
4.453900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.581500E-03 |
| Normal-vs-Female |
6.091400E-01 |
| Male-vs-Female |
1.736400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.746200E-01 |
| Normal-vs-Extreme_Weight |
6.271800E-02 |
| Normal-vs-Obese |
2.754200E-02 |
| Normal-vs-Extreme_Obese |
6.182400E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.190780E-01 |
| Normal_Weight-vs-Obese |
5.922300E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.820100E-02 |
| Extreme_Weight-vs-Obese |
6.837000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.511600E-01 |
| Obese-vs-Extreme_Obese |
4.515800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.735400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.838350E-02 |
| Normal-vs-Age(61-80Yrs) |
1.384050E-01 |
| Normal-vs-Age(81-100Yrs) |
5.850800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.387000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.718200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.297800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.953600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.473200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.766600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.78600000034469E-07 |
| Normal-VS-Type2 PRCC |
2.517200E-01 |
| Normal-VS-KIRP CIMP |
1.319800E-02 |
| Normal-VS-Unclassified PRCC |
8.388800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.97999999413435E-09 |
| Type1 PRCC-VS-KIRP CIMP |
7.642400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.995800E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.897410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.852600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.271500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.764760E-01 |
| Normal-vs-N1 |
1.063970E-01 |
| Normal-vs-N2 |
9.502400E-02 |
| N0-vs-N1 |
2.617700E-02 |
| N0-vs-N2 |
6.246600E-01 |
| N1-vs-N2 |
8.362300E-02 |
|
|
